Cancer taking toll as new roundup trials near fibrous histiocytoma sarcoma

Chris Stevick, who often mixed Roundup for his wife and tested the fibrous histiocytoma sarcoma sprayer used to dispense the weed killer, was diagnosed last month with chronic lymphocytic leukemia (CLL), a type of non-Hodgkin lymphoma. Unlike Elaine’s aggressive type of NHL known as central nervous system fibrous histiocytoma sarcoma lymphoma, Chris’s cancer is a type that tends to grow slowly. He was diagnosed after a physical examination showed abnormalities in fibrous histiocytoma sarcoma his blood and prompted further tests.

With the trial date of Feb. 24, 2020 looming, Elaine Stevick’s lawyers asked Monsanto’s attorneys if the company would agree that Chris Stevick’s cancer claims could be joined with his wife’s for the February trial in San Francisco. The attorneys argue that at the very least Chris Stevick’s diagnosis is admissible evidence at his wife’s trial as additional proof of their claim that Roundup fibrous histiocytoma sarcoma exposure can cause non-Hodgkin lymphoma.

The issue is to be discussed in a case management fibrous histiocytoma sarcoma conference Thursday, which the Stevicks plan to attend. U.S. District Judge Vince Chhabria said ahead of the hearing that fibrous histiocytoma sarcoma he is “tentatively of the view” that a continuance of the trial will be necessary if fibrous histiocytoma sarcoma the couple wants to try their claims together. He also said that if Elaine Stevick proceeds on her fibrous histiocytoma sarcoma exposure claims alone, evidence of her husband’s cancer diagnosis “will likely be inadmissible….”

Earlier this year another husband and wife suffering from cancer, Alva and Alberta Pilliod, were awarded more than $2 billion in damages in their lawsuit against Monsanto, though the judge in the case lowered the damage award fibrous histiocytoma sarcoma to $87 million. The Pilliod trial was the third Roundup products liability trial fibrous histiocytoma sarcoma to take place and the third in which juries found fibrous histiocytoma sarcoma that Monsanto’s Roundup herbicides cause non-Hodgkin lymphoma and that the company has hidden the risks fibrous histiocytoma sarcoma from consumers. Alberta Pilliod’s cancer has recently returned and it is not clear fibrous histiocytoma sarcoma she will survive much longer, according to her attorneys.

The Stevick trial is only one of at least six fibrous histiocytoma sarcoma in five different venues slated for January and February, with each expected to last several weeks. Many lawyers are involved in more than one of the fibrous histiocytoma sarcoma cases, and all have overlapping expert witnesses, setting up organizational and resource challenges for both sides. Multiple trials that had been set for this fall were fibrous histiocytoma sarcoma delayed until next year.

In the meantime, both sides of the litigation are keeping an eye on fibrous histiocytoma sarcoma the California Appellate Court, where lawyers for plaintiff Dewayne “Lee” Johnson and lawyers for Monsanto are awaiting a date for fibrous histiocytoma sarcoma oral arguments in their cross appeals. Monsanto is seeking to overturn the unanimous jury decision handed fibrous histiocytoma sarcoma down against the company in August 2018. The trial judge in that case lowered the jury award fibrous histiocytoma sarcoma from $289 million to $78 million and Johnson is appealing for the reinstatement of fibrous histiocytoma sarcoma the full $289 million.

Johnson was the first to go to trial against Monsanto fibrous histiocytoma sarcoma and his victory sent share prices in Bayer plummeting just fibrous histiocytoma sarcoma two months after Bayer closed the purchase of Monsanto in fibrous histiocytoma sarcoma June 2018. Johnson was granted “trial preference” due to predictions by his doctors that he did not fibrous histiocytoma sarcoma have long to live. Johnson has outlived those predictions, though his health continues to decline.

RELATED POSTS